September 1, 2010 (Cincinnati, Ohio) BioRx and Hemophilia of North Carolina announce the availability of four 2011 BioRx Educational Scholarships in the amount of $2,000 each to individuals with bleeding disorders. The scholarships will be awarded for the 2011-2012 school year, and the deadline for submitting applications is May 1, 2011. Read the rest of this entry »
BioRx and Hemophilia of North Carolina announce the availability of four 2011 BioRx Educational Scholarships, in the amount of $2,000 each, to individuals with bleeding disorders*. The scholarships will be awarded for the 2011-2012 school year, and the deadline for submitting applications is May 1, 2011. Read the rest of this entry »
June 14, 2010 (Cincinnati, Ohio) BioRx, a specialty pharmacy, and Hemophilia of North Carolina, a non-profit organization that assists and educates persons affected by bleeding disorders, announce the winners of the 2010 BioRx Educational Scholarships. Each of the winners receives a $2,000 scholarship. The scholarships are funded by BioRx through an educational grant, which is administered by Hemophilia of NC, a chapter of the National Hemophilia Foundation. Read the rest of this entry »
July 20, 2010 (Cincinnati, Ohio) – Philip Rielly, President and Co-founder of specialty pharmacy BioRx LLC, has received the Ernst & Young Entrepreneur Of The Year® 2010 Award in the Healthcare category in South Central Ohio and Kentucky. Read the rest of this entry »
March 8, 2010 (Cincinnati, Ohio) - Cincy magazine has announced BioRx as a finalist in its First Annual Tristate Success Awards. Read the rest of this entry »
December 3, 2009 (Cincinnati, Ohio) - The Cincinnati Business Courier has announced that BioRx is again a finalist in its 2009 Fast 55 Award, ranking 4th in the $50.1 to $199 million category.
Read the rest of this entry »
December 7, 2009 (Cincinnati, Ohio) - BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.
Read the rest of this entry »
November 9, 2009 (Cincinnati, Ohio) - BioRx, a specialty pharmaceutical company, announces the availability of a free 2010 calendar to the hemophilia community. The annual BioRx Kids Hemophilia Calendar features artwork from children who either have a bleeding disorder or have a sibling or parent with a bleeding disorder.
Read the rest of this entry »
August 8, 2009 (Cincinnati, Ohio) - Bayer HealthCare and BioRx, a specialty pharmaceutical company, announce the availability of Quest for Infusion: Nate Goes to Camp, a new children’s book about hemophilia.
Read the rest of this entry »
June 11, 2009 (Cincinnati, Ohio) - BioRx announces a new Off-to-College Brochure, with a checklist to help PIDD patients and their families prepare for college. The brochure is available free of charge to individuals with primary immune deficiency disorders and their caregivers.
Read the rest of this entry »
